Drug
Bnt163
Bnt163: highest development phase Phase 1, developed by BioNTech. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BioNTech
Trials
| Drug | Phase | Indication |
|---|---|---|
| BNT163 NCT05432583 | Phase 1 | Genital Herpes Simplex Type 2 |
Latest
No recent events.
Follow Bnt163 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.